RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,425,745 | +18.2% | 975,147 | +1.8% | 0.00% | – |
| Q2 2023 | $6,283,516 | +230.4% | 957,853 | +201.2% | 0.00% | – |
| Q1 2023 | $1,901,532 | +156.7% | 317,982 | 0.0% | 0.00% | – |
| Q4 2022 | $740,898 | -30.6% | 317,982 | -0.3% | 0.00% | – |
| Q3 2022 | $1,068,000 | +26.4% | 318,814 | 0.0% | 0.00% | – |
| Q2 2022 | $845,000 | -20.4% | 318,814 | -11.7% | 0.00% | – |
| Q1 2022 | $1,061,000 | -66.2% | 360,881 | -1.8% | 0.00% | – |
| Q4 2021 | $3,142,000 | +11.6% | 367,596 | -2.7% | 0.00% | – |
| Q3 2021 | $2,815,000 | -17.6% | 377,753 | +3.2% | 0.00% | – |
| Q2 2021 | $3,417,000 | – | 366,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |